Related Experiment Video
Updated: May 29, 2026

Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Lamotrigine withdrawal may worsen RBD symptoms
Nicholas Tiberio Economou1, Anastasios Bonakis, Apostolia Ghika
1Sleep Center-Neurocenter (EOC) of Southern Switzerland, Lugano, Switzerland. nt_economou@yahoo.it
Background:
Rapid eye movement (REM) behavior disorder (RBD) is a rapid eye movement parasomnia, which in its symptomatic type could be induced by the introduction or the discontinuation of several drugs and substances. No references for antiepileptic drugs and especially for lamotrigine are known regarding pharmacologically induced RBD.
Case Report:
We report a case of a 68-year-old man already suffering from RBD, who developed very brief episodes of epigastric discomfort followed by impaired consciousness and was given a diagnosis of epilepsy. Lamotrigine was started at 25 mg/d, reached a maximum of 100 mg/d after 2 months and was retained at this dose for 1 more month. During this period there was a slight decrease in the episodes of impaired consciousness and no appreciable changes in the frequency and intensity of RBD symptomatology. Immediately following the abrupt discontinuation of lamotrigine, RBD symptomatology was severely aggravated, with dreams becoming more vivid and frightening and occurring almost every night. RBD symptomatology gradually subsided over 2 months, reaching levels comparable to those before lamotrigine. The impaired consciousness episodes remained unaffected and were considered to be nonepileptic.
Conclusions:
Our findings suggest that abrupt withdrawal of lamotrigine may worsen symptoms of comorbid idiopathic RBD.
Related Concept Videos
REM Sleep Behavior Disorder
RBD is significantly associated with...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Mania and Antimanic Drugs: Overview
Antiepileptic Drugs: Glutamate Antagonists
